November 24, 2025: Ozempic Share Prices Fall After Clinical Trial Results and Mounting Lawsuits Shares for Novo Nordisk, Ozempics owner, fell to their lowest level since 2021

Specific cardiac considerations include: Heart rhythm concerns: The heart rate-increasing effect may require additional monitoring in patients with atrial fibrillation, supraventricular tachycardia, or ventricular arrhythmias Heart failure: Patients with New York Heart Association (NYHA) Class III-IV heart failure were excluded from major clinical trials, and there is limited safety data in this population [18] [21] Recent cardiac events: Patients with recent myocardial infarction, stroke, or unstable angina may require individualized assessment during the recovery period Hemodynamic considerations: Rapid weight loss may affect fluid balance in patients with significant cardiac disease Adverse effects relevant to cardiac patients include gastrointestinal symptoms (nausea, vomiting, diarrhea) that may lead to dehydration and electrolyte disturbances
Secondary endpoints included 3P-MACE components, hospitalization for heart failure, revascularizations, and adverse events
Discussion In this nationally representative modelling study, an estimated 6.1 million U.S
and Pfizer Inc
& Offermanns, S